UNRESECTABLE ESOPHAGEAL CARCINOMA
Clinical trials for UNRESECTABLE ESOPHAGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE ESOPHAGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE ESOPHAGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for tough stomach cancers
Disease control CompletedThis study tested two drugs, olaparib and ramucirumab, in 51 people with advanced stomach or gastroesophageal junction cancer that had spread or could not be removed. The goal was to find the best dose and see how well the combination worked. The trial is complete, and results ma…
Matched conditions: UNRESECTABLE ESOPHAGEAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Zinc may boost quality of life for advanced cancer patients on chemo
Symptom relief CompletedThis study looked at whether taking zinc supplements can improve quality of life for people with advanced gastrointestinal cancers (like stomach, liver, or pancreatic cancer) who are receiving chemotherapy. Seventeen patients participated, and researchers measured their quality o…
Matched conditions: UNRESECTABLE ESOPHAGEAL CARCINOMA
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC